Skip to main content
. 2009 Dec 9;7:103. doi: 10.1186/1479-5876-7-103

Figure 7.

Figure 7

Peptide-specific interferon-γ release of CTLs. PBMCs of HLA-A24-positive prostate cancer patient (case 6) were stimulated four times with four kinds of AMACR peptide (AMACR1-4)-pulsed APCs and peptide-specific interferon-γ release was analyzed by ELISPOT assay. CTLs could release interferon-γ in response to AMACR1, 2 and 3 peptides, but not in response to AMACR4 peptide or HIV peptide.